442 material Form 8-K filings that 386 companies we cover made with the SEC in March 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
NBT Bancorp amended its supplemental retirement agreement with Scott Kingsley, increasing his annual Pay Based Credits by $500,000 so that total annual company-provided retirement contributions are not less than $1,000,000 starting with the 2025 Plan Year. The amendment is a compensation change for a named officer and is filed as Exhibit 10.1. The filing gives conflicting dates for the amendment, May 24, 2025 in the text and March 24, 2025 in the exhibit description.
Pay Based Credits increased by $500,000 per year under the SERP Amendment
Total annual company-provided retirement contributions for Mr. Kingsley not less than $1,000,000, effective with the 2025 Plan Year
Text says the amendment was entered into May 24, 2025; Exhibit 10.1 is dated March 24, 2025, and the filing is dated March 24, 2025
BioLife Solutions appointed Catherine Coste, a former Deloitte senior partner and licensed CPA, to its board effective March 18, 2025, increasing board membership to seven. She also replaces Joydeep Goswami as audit committee chair, with Goswami remaining a director and audit committee member. The filing describes the change as a board and governance update and does not report any financial results.
Coste's appointment is effective March 18, 2025, and she serves until the 2025 Annual Meeting of Stockholders.
Board membership increases to seven; Coste replaces Joydeep Goswami as audit committee chair.
Coste retired from Deloitte in September 2020 after more than 32 years with the firm.
Coste will receive the same prorated compensation as the company's other non-employee directors.
Southside Bancshares said its board acknowledged the retirements of directors Tony K. Morgan, John F. Sammons, Jr. and Donald W. Thedford, effective when their terms expire at the 2025 Annual Meeting scheduled for May 14, 2025. The retirements follow the company's mandatory age requirement under its Director Departure Policy and are not due to any disagreement with the board or management, and the three also leave the board of subsidiary Southside Bank.
Directors Tony K. Morgan, John F. Sammons, Jr. and Donald W. Thedford will retire at the 2025 Annual Meeting, scheduled for May 14, 2025.
Morgan and Sammons have served on the board since 2017; Thedford has served since 2009.
The retirements are under the mandatory age requirement in the Director Departure Policy and are not due to any disagreement with the board or management.
The three directors also serve on the board of Southside Bank and will retire from that role at the same time.
Somnigroup International said it determined, after its acquisition of Mattress Firm Group, to reevaluate its executive team reporting structure. As a result, Scott Vollet, Executive Vice President, Global Operations of Tempur Sealy International, will no longer function as an executive officer or Section 16 insider. The filing does not give a reason beyond the reorganization or name a successor.
Scott Vollet, EVP, Global Operations of Tempur Sealy International, will no longer be an executive officer or Section 16 insider
The change follows the previously reported acquisition of Mattress Firm Group LLC
Filing dated March 24, 2025, signed by CFO Bhaskar Rao
Five9 said audit committee chair Jack Acosta, a Class II director, will not be nominated for re-election at the May 21, 2025 annual meeting. Board changes also include Jonathan Mariner's reappointment as a Class II director and Maria Walker taking over as Audit Committee chair after the meeting, with the Board shrinking to nine directors.
Jack Acosta will not stand for re-election as a Class II director at the May 21, 2025 annual meeting; the filing thanks him for his service as Audit Committee chair.
Jonathan Mariner resigned as a Class III director on March 19, 2025 and was immediately reappointed as a Class II director, with his term ending at the annual meeting.
Maria Walker will become Audit Committee chair at the conclusion of the annual meeting.
The Board will be reduced to nine directors, with Class II reduced to three after the annual meeting, and Mr. Mariner will not receive a new director RSU grant.
Standex International said Chief Accounting Officer Amy Gagnon will step down effective May 2, 2025, citing personal family obligations. Danielle Rangel, the company's Vice President of Internal Audit and Investigations, will succeed her in the role on the same date. The change affects a key financial reporting position, though the filing describes it as a planned internal promotion.
Amy Gagnon notified Standex on March 19, 2025 that she will step down as Chief Accounting Officer effective May 2, 2025
Danielle Rangel, age 43, will become Vice President and Chief Accounting Officer effective May 2, 2025
Rangel joined Standex in May 2023 as Vice President of Internal Audit and Investigations and previously held finance roles at Carlisle Fluid Technologies
Rangel will participate in the company's Executive Severance Policy
Sabra Health Care REIT said Chief Investment Officer Talya Nevo-Hacohen will retire effective December 31, 2025, and Executive Vice President Darrin Smith is expected to take the CIO role effective January 1, 2026. Nevo-Hacohen will serve as an independent consultant through December 31, 2027, for an annual fee of $900,000, which the filing describes as a planned transition.
Talya Nevo-Hacohen retires as Chief Investment Officer and Treasurer effective December 31, 2025
Darrin Smith, Executive Vice President, Investments, expected to become Chief Investment Officer effective January 1, 2026
Consulting Agreement dated March 20, 2025 provides an annual consulting fee of $900,000 and runs through December 31, 2027
Filing contains no financial results or guidance; Chair and CEO Rick Matros signed the report
Harmony Biosciences said Chief Commercial Officer Jeffrey Dierks is leaving for personal reasons, effective March 31, 2025, and named Adam Zaeske, formerly a senior executive at Takeda Pharmaceuticals, as his successor on the same date. Dierks's separation agreement provides a $476,215 lump-sum payment and accelerated vesting of part of his equity awards. The company's CEO said the company remains confident in its 2025 revenue guidance.
Jeffrey Dierks departs as Chief Commercial Officer effective March 31, 2025, for personal reasons
Separation agreement dated March 20, 2025 provides a $476,215 lump-sum payment and accelerated vesting of awards for the portion that would have vested in calendar 2025
Adam Zaeske becomes Executive Vice President and Chief Commercial Officer effective March 31, 2025; he previously served as Senior Vice President at Takeda Pharmaceuticals from April 2022 to March 2025
CEO Jeffrey Dayno said the company remains confident in its 2025 revenue guidance
Hilton Grand Vacations said CFO Daniel Mathewes is returning from a temporary personal leave of absence effective March 24, 2025, resuming his duties. Erin Day, who had served as acting CFO during the leave, stops in that role and remains Executive Vice President, Finance. The filing gives no financial results, and the change restores the regular CFO to his position.
Daniel J. Mathewes, President and Chief Financial Officer, returns from temporary personal leave effective March 24, 2025
Erin Day ceases as acting CFO and continues as Executive Vice President, Finance
The filing was signed by Charles R. Corbin, Senior Executive Vice President, General Counsel and Secretary, dated March 24, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.